Reduction and Escalation in the Dose of Sunitinib Were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine

We herein report the first case in which an escalated dose of sunitinib was effective, even after dose reduction. A 64-year-old man with gastrointestinal stromal tumor of the small intestine discontinued adjuvant imatinib because of interstitial pneumonia. After two years, peritoneal recurrence was...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Misato, Satake, Hironaga, Ogata, Takatsugu, Hatachi, Yukimasa, Hara, Shigeo, Hirota, Seiichi, Yasui, Hisateru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911760/
https://www.ncbi.nlm.nih.gov/pubmed/31327822
http://dx.doi.org/10.2169/internalmedicine.2806-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911760/
https://www.ncbi.nlm.nih.gov/pubmed/31327822
http://dx.doi.org/10.2169/internalmedicine.2806-19

Ejemplares similares